Found 4 matching trials
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.75.01015 Boehringer Ingelheim Investigational Site
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.70.01068 Boehringer Ingelheim Investigational Site
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.71.01034 Boehringer Ingelheim Investigational Site
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
PHASE3To determine if long-term treatment with Flibanserin is safe and to monitor...
Location
511.84.01079 Boehringer Ingelheim Investigational Site